CompletedN/Aketamine
Lidocaine and Ketamine Levels in Plasma After Simultaneous Lidocaine/Ketamine Infusions
Sponsored by University Hospital, Basel, Switzerland
NCT ID
NCT05906121
Target Enrollment
15 participants
Start Date
2023-05-16
Est. Completion
2024-08-31
About This Study
The aim of this monocentric observational pilot study is to measure the lidocaine plasma level in a limited number of patients to generate explorative data on inter- and intrapersonal stability and safety of drug plasma levels and to investigate whether higher plasma levels of ketamine can be correlated with a better analgesic effect.
Conditions Studied
Interventions
- •lidocaine-ketamine infusions
Eligibility
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Patient is a new recipient of lidocaine-ketamine infusions * Patient is able to provide Informed Consent Exclusion Criteria: * Contraindication to blood sampling (on arm not used for infusion) * Insufficient knowledge of German language * Inability to give consent * Patient is under 18 years of age * Contraindication to treatment with lidocaine and/or ketamine
Study Locations (1)
Department of Anaesthesiology, University Hospital of Basel (USB)
Basel, Switzerland